Suppr超能文献

叠加的整体与单个导联心电图复合波之间QT间期差异的幅度、机制及可重复性。

Magnitude, mechanism, and reproducibility of QT interval differences between superimposed global and individual lead ECG complexes.

作者信息

Kligfield Paul, Tyl Benoit, Maarek Martine, Maison-Blanche Pierre

机构信息

Department of Medicine, Division of Cardiology, Weill Medical College of Cornell University, New York, NY 10021, USA.

出版信息

Ann Noninvasive Electrocardiol. 2007 Apr;12(2):145-52. doi: 10.1111/j.1542-474X.2007.00153.x.

Abstract

BACKGROUND

The global QT interval, emerging as a standard measurement provided by digital electrocardiographs, is defined by the earliest QRS onset and latest T-wave offset that occur in any of the standard leads. Differences between global ECG measurements and those from individual ECG leads have implications for the redefinition of normal values, for recognition of disease, and for drug safety. This study sought to quantify the differences between global QT intervals measured from 12 superimposed ECG leads with QT intervals and from single lead complexes, to examine the separate effects of QRS onset and T-wave offset on these differences, and to examine the reproducibility of these measurements.

METHODS

QTo intervals (Q onset to T offset) from 50 digitized ECGs sampled at 500 Hz were examined by computer assisted derivation of representative complexes from standard leads II, V(2), and V(3), by both baseline and tangent methods. Global QTo intervals were measured from superimposition of the representative complexes of all 12 leads. A time-coherent matrix of waveform onset and offset points allowed direct comparison of the components of the differences.

RESULTS

Global QTo and Bazett-adjusted global QTc were greater than each of the baseline and tangent measurements in representative leads II, V(2), and V(3), with mean differences ranging from 8 to 18 ms. QRS onset was earlier in the global complex than in each of the representative leads, with mean differences of 3-5 ms, whereas T-wave offset was significantly later in the global complex than in each of the representative leads, with mean differences of 5-11 ms. Remeasurement of all ECGs after an interval of 6 months confirmed the relative magnitudes of the global and individual lead QTo durations and small mean differences between pairs (-0.9 to 2.7 ms). Although global QTo had the largest mean difference (only 2.7 ms), it had the smallest standard deviation of the mean difference and lowest coefficient of variability (1.58%) of all measurements.

CONCLUSION

Global QT measurements are systematically larger than measurements from representative complexes of individual leads. These differences result from the combined effects of earlier QRS onset and later T-wave offset in the global complex, with T-wave offset the more dominant component of the difference.

摘要

背景

整体QT间期作为数字心电图提供的一项标准测量指标,由任何标准导联中最早的QRS波起始点和最晚的T波终点来定义。整体心电图测量值与各个心电图导联测量值之间的差异对正常值的重新定义、疾病的识别以及药物安全性均有影响。本研究旨在量化从12个叠加心电图导联测量的整体QT间期与单个导联复合波的QT间期之间的差异,研究QRS波起始点和T波终点对这些差异的单独影响,并检验这些测量值的可重复性。

方法

通过计算机辅助从标准导联II、V(2)和V(3)中推导代表性复合波,采用基线法和切线法,对50份以500Hz采样的数字化心电图的QTo间期(从Q波起始到T波终点)进行检测。整体QTo间期通过叠加所有12个导联的代表性复合波来测量。波形起始点和终点的时间相干矩阵允许直接比较差异的各个组成部分。

结果

整体QTo间期和Bazett校正的整体QTc间期均大于代表性导联II、V(2)和V(3)中的基线测量值和切线测量值,平均差异范围为8至18毫秒。整体复合波中的QRS波起始点比每个代表性导联中的更早,平均差异为3 - 5毫秒,而整体复合波中的T波终点比每个代表性导联中的明显更晚,平均差异为5 - 11毫秒。6个月后对所有心电图进行重新测量,证实了整体和单个导联QTo间期的相对大小以及各对测量值之间较小的平均差异(-0.9至2.7毫秒)。尽管整体QTo间期的平均差异最大(仅2.7毫秒),但其平均差异的标准差最小,且在所有测量值中变异系数最低(1.58%)。

结论

整体QT测量值系统性地大于单个导联代表性复合波的测量值。这些差异是由整体复合波中更早出现QRS波起始点和更晚出现T波终点的综合作用导致的,其中T波终点是差异中更主要的组成部分。

相似文献

1
Magnitude, mechanism, and reproducibility of QT interval differences between superimposed global and individual lead ECG complexes.
Ann Noninvasive Electrocardiol. 2007 Apr;12(2):145-52. doi: 10.1111/j.1542-474X.2007.00153.x.
2
QT interval-heart rate relation during exercise in normal men and women: definition by linear regression analysis.
J Am Coll Cardiol. 1996 Nov 15;28(6):1547-55. doi: 10.1016/s0735-1097(96)00351-8.
5
The development and validation of an easy to use automatic QT-interval algorithm.
PLoS One. 2017 Sep 1;12(9):e0184352. doi: 10.1371/journal.pone.0184352. eCollection 2017.
6
Comparison of automated interval measurements by widely used algorithms in digital electrocardiographs.
Am Heart J. 2018 Jun;200:1-10. doi: 10.1016/j.ahj.2018.02.014. Epub 2018 Feb 26.
7
QT interval measurement in the dog: chest leads versus limb leads.
J Pharmacol Toxicol Methods. 2004 Nov-Dec;50(3):201-7. doi: 10.1016/j.vascn.2004.05.004.
8
Comparing methods of measurement for detecting drug-induced changes in the QT interval: implications for thoroughly conducted ECG studies.
Ann Noninvasive Electrocardiol. 2004 Apr;9(2):166-74. doi: 10.1111/j.1542-474X.2004.92542.x.
9
Methodology of QT-interval measurement in the modular ECG analysis system (MEANS).
Ann Noninvasive Electrocardiol. 2009 Jan;14 Suppl 1(Suppl 1):S48-53. doi: 10.1111/j.1542-474X.2008.00261.x.
10
Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
Pacing Clin Electrophysiol. 2004 Dec;27(12):1659-69. doi: 10.1111/j.1540-8159.2004.00701.x.

引用本文的文献

1
Prevalence and predictors of false positive QTc prolongation by the automated measurement.
Front Cardiovasc Med. 2024 Oct 10;11:1465264. doi: 10.3389/fcvm.2024.1465264. eCollection 2024.
2
Automatic identification of a stable QRST complex for non-invasive evaluation of human cardiac electrophysiology.
PLoS One. 2020 Sep 17;15(9):e0239074. doi: 10.1371/journal.pone.0239074. eCollection 2020.
4
Automatic Identification of the Repolarization Endpoint by Computing the Dominant T-wave on a Reduced Number of Leads.
Open Biomed Eng J. 2016 Apr 30;10:43-50. doi: 10.2174/1874120701610010043. eCollection 2016.
5
Predictive Power of f99 Repolarization Index for the Occurrence of Ventricular Arrhythmias.
Ann Noninvasive Electrocardiol. 2016 Mar;21(2):152-60. doi: 10.1111/anec.12274. Epub 2015 Nov 25.
6
A pilot study of QT interval analysis in overweight and obese youth.
Appl Nurs Res. 2012 Aug;25(3):218-21. doi: 10.1016/j.apnr.2010.11.003. Epub 2011 Jan 20.
7
The thorough QT/QTc study 4 years after the implementation of the ICH E14 guidance.
Br J Pharmacol. 2010 Jan;159(1):49-57. doi: 10.1111/j.1476-5381.2009.00487.x. Epub 2009 Nov 18.

本文引用的文献

1
Relation of QT interval measurements to evolving automated algorithms from different manufacturers of electrocardiographs.
Am J Cardiol. 2006 Jul 1;98(1):88-92. doi: 10.1016/j.amjcard.2006.01.060. Epub 2006 May 6.
2
Drugs, QT interval prolongation and ICH E14: the need to get it right.
Drug Saf. 2005;28(2):115-25. doi: 10.2165/00002018-200528020-00003.
3
Congenital and acquired long QT syndrome. Current concepts and management.
Cardiol Rev. 2004 Jul-Aug;12(4):222-34. doi: 10.1097/01.crd.0000123842.42287.cf.
4
A definitive or thorough phase 1 QT ECG trial as a requirement for drug safety assessment.
J Electrocardiol. 2004 Jan;37(1):25-9. doi: 10.1016/j.jelectrocard.2003.11.004.
5
Drug-induced cardiac toxicity: emphasizing the role of electrocardiography in clinical research and drug development.
J Electrocardiol. 2004 Jan;37(1):19-24. doi: 10.1016/j.jelectrocard.2003.11.003.
6
Comparing methods of measurement for detecting drug-induced changes in the QT interval: implications for thoroughly conducted ECG studies.
Ann Noninvasive Electrocardiol. 2004 Apr;9(2):166-74. doi: 10.1111/j.1542-474X.2004.92542.x.
8
Electrocardiographic identification of drug-induced QT prolongation: assessment by different recording and measurement methods.
Ann Noninvasive Electrocardiol. 2004 Jan;9(1):48-57. doi: 10.1111/j.1542-474x.2004.91546.x.
9
The significance of QT interval in drug development.
Br J Clin Pharmacol. 2002 Aug;54(2):188-202. doi: 10.1046/j.1365-2125.2002.01627.x.
10
QTc interval in the assessment of cardiac risk.
Card Electrophysiol Rev. 2002 Sep;6(3):289-94. doi: 10.1023/a:1016345412555.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验